Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals

Por Anne-Céline Martin MD, PhD, Wei Huang PhD, Samuel Z. Goldhaber MD, Russell D. Hull MD, Adrian F. Hernandez MD, Charles-Michael Gibson MD, Frederick A. Anderson PhD, Alexander T. Cohen MD
Publicado em 2019-10-01

Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy

Por Kevin McLaughlin PharmD, BCPS, Jessica Rimsans PharmD, BCPS, Katelyn W. Sylvester PharmD, BCPS, CACP, John Fanikos Rph, MBA, David M. Dorfman MD, PhD, Patricia Senna MT, ASCP, Jean M. Connors MD, Samuel Z. Goldhaber MD
Publicado em 2019-09-01